This article was originally published in The Gray Sheet
Executive SummaryOne detail in the draft guidance that may catch the attention of some in industry is in the section on technology, engineering and performance changes.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.